LightOx Ltd
Clive Henry Cole Sims has a diverse work experience in the field of biology and biomedical sciences. Clive Henry Cole'smost recent position is as a Biology Team Leader at LightOx, where they lead the team in developing innovative treatments for oral cancers and dysplasias. Clive Henry Cole also co-leads the grant writing for Innovate UK at LightOx.
Prior to that, they worked as a Postdoctoral Research Associate at Newcastle University, where they focused on gene editing strategies for prostate cancer. Clive Henry Cole was responsible for designing, implementing, and analyzing cloning experiments, as well as supervising undergraduate and postgraduate students. Clive Henry Cole also served as a Teaching Fellow in Biomedical Sciences, teaching and leading practical sessions for undergraduate and postgraduate students.
Clive's earlier experience includes working as a PhD student in Molecular Cardiology at The University of Manchester. During their PhD, they developed an improved CRISPR/Cas9 methodology and established a differentiation protocol for hESCs into beating cardiomyocytes. Clive Henry Cole also had a research assistant role at the Institute of Molecular and Cell Biology, A*STAR, Singapore, where they focused on stem cell-derived cardiomyocytes and MAPK signaling.
Before their research career, Clive served as a Student Trustee on the Board of Directors at Durham Students Union. In this role, they were involved in financial decision-making and ensuring the Union's standing orders were approved by the University Executive Committee.
Overall, Clive's work experience demonstrates their expertise in biology, gene editing, teaching, and leadership.
Clive Henry Cole Sims completed their education in a chronological order. Clive Henry Cole began their academic journey in 2009 at Durham University, where they pursued a Bachelor of Science (BSc) Hons degree in Natural Sciences. Clive Henry Cole studied at Durham University for four years, completing their undergraduate degree in 2013.
Following their undergraduate studies, Clive went on to pursue a Master of Science (MSc) degree in Stem Cell Biology. Clive Henry Cole attended Durham University again for this program and completed it in 2014.
Clive's educational journey continued with their admission to The University of Manchester in 2014. Clive Henry Cole enrolled in a Doctor of Philosophy (Ph.D.) program with a focus on Molecular Cardiology. Clive Henry Cole dedicated four years to their doctoral research and successfully completed their Ph.D. in the year 2018.
Throughout their educational history, Clive Henry Cole Sims progressed from their undergraduate degree in Natural Sciences to a Master's degree in Stem Cell Biology and ultimately achieved a Ph.D. in Molecular Cardiology.
This person is not in any teams
LightOx Ltd
Lightox has developed a unique range of molecular tools for use in imaging, therapeutics and assay development. These unique probes are smaller than any other commercially available fluorescent product. They offer the option of using our technologies as freely-moving probes that readily incorporate into cells or with a range of flexible linkers togive specificity to your unique applications and research needs.